BCL2 and glioblastoma: Wang et al. reported the synergetic effect of apigenin in combination with TMZ against TMZ-resistant GBM cells by increasing the chemosensitivity of TMZ by decreasing MMP-2 and 9, BCL-2, AKT phosphorylation, and cyclin D1 [285].